Immunologically “hot” tumors comprise high numbers of tumor-infiltrating lymphocytes (TILs) and increased PD-1 ligand expression, whereas immunologically “cold” tumors have low numbers of TILs and reduced PD-1 expression. The gene discussed is PDCD1; the disease is neoplasm.